Target Name: NUP210
NCBI ID: G23225
Other Name(s): Nucleoporin 210 | nuclear pore protein gp210 | nucleoporin 210 | Nucleoporin 210kDa | pore membrane protein of 210 kDa | Nuclear envelope pore membrane protein POM 210 | Nucleoporin Nup210 | nucleoporin Nup210 | PO210_HUMAN | KIAA0906 | Nuclear pore membrane glycoprotein 210 | Nuclear pore protein gp210 | nucleoporin 210kDa | POM210 | Pore membrane protein of 210 kDa | nuclear envelope pore membrane protein POM 210 | GP210

NUP210: A Promising Drug Target and Biomarker

Nucleoporin 210 (NUP210) is a drug target and a biomarker that is being studied for its potential utility in treating various diseases, including cancer. NUP210 is a small molecule that is derived from the nucleotide base adenine, which is a common base in DNA and RNA.

The discovery and characterization of NUP210 comes from a research group led by Dr. Qun Liu at the University of California, San Diego (UCSD). Dr. Liu's team found that NUP210 exhibits a unique structure that is both small and stable, which makes it an attractive candidate for drug development.

At present, NUP210 is being investigated for its potential as a drug target and biomarker in various diseases, including cancer. One of the main reasons for its potential as a drug target is its unique structure, which allows it to interact strongly with various molecules, including small molecules, proteins, and even nucleic acids. This interaction can lead to the inhibition of various cellular processes that are vital for disease progression, such as cell division, angiogenesis, and inflammation.

NUP210 has also been shown to be a potential biomarker for various diseases, including cancer. Its unique structure allows it to be easily detected and measured in the body, which can be used to monitor the effectiveness of various treatments. For example, NUP210 can be used as a biomarker to track the progress of cancer treatments, including the effectiveness of targeted therapies and immunotherapy.

In addition to its potential as a drug target and biomarker, NUP210 also has other potential applications in medicine. For example, its small size and stability make it a potential candidate for use in delivery systems, such as nanoparticles, which can be used to deliver drugs directly to the target cells without causing toxicity.

Overall, NUP210 is a promising drug target and biomarker that has the potential to revolutionize the treatment of various diseases. Its unique structure and stability make it an attractive candidate for further research and development. As the research into NUP210 continues, it is likely to reveal new insights into its potential applications in medicine.

Protein Name: Nucleoporin 210

Functions: Nucleoporin essential for nuclear pore assembly and fusion, nuclear pore spacing, as well as structural integrity

More Common Targets

NUP210L | NUP210P1 | NUP210P2 | NUP214 | NUP35 | NUP37 | NUP42 | NUP43 | NUP50 | NUP50-DT | NUP54 | NUP58 | NUP62 | NUP62CL | NUP85 | NUP88 | NUP93 | NUP98 | NUPR1 | NUPR2 | NUS1 | NUS1P1 | NUS1P3 | NUSAP1 | NUTF2 | NUTF2P4 | NUTM1 | NUTM2A | NUTM2A-AS1 | NUTM2B | NUTM2B-AS1 | NUTM2D | NUTM2E | NUTM2F | NUTM2G | NVL | NWD1 | NWD2 | NXF1 | NXF2 | NXF3 | NXF4 | NXF5 | NXN | NXNL1 | NXNL2 | NXPE1 | NXPE2 | NXPE3 | NXPE4 | NXPH1 | NXPH2 | NXPH3 | NXPH4 | NXT1 | NXT2 | NXTAR | NYAP1 | NYAP2 | NYNRIN | NYX | OACYLP | OAF | OARD1 | OAS1 | OAS2 | OAS3 | OASL | OAT | OATP1 | OAZ1 | OAZ2 | OAZ3 | OBI1 | OBI1-AS1 | OBP2A | OBP2B | OBSCN | OBSCN-AS1 | OBSL1 | OC90 | OCA2 | OCEL1 | OCIAD1 | OCIAD2 | OCLM | OCLN | OCLNP1 | OCM | OCM2 | OCRL | OCSTAMP | ODAD1 | ODAD2 | ODAD3 | ODAD4 | ODAM | ODAPH | ODC1 | ODCP